Jaffetilchin Investment Partners, LLC Paratek Pharmaceuticals, Inc. Transaction History

Jaffetilchin Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 17, 2022	SELL	$4.07 - $5.3 $51,587 - $67,177	-12,675 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$4.7 - $7.24 $59,572 - $91,767	-12,675 Reduced 50.0%	12,675 $62,000
Q2 2021 Aug 09, 2021	BUY	$6.81 - $10.93 $86,316 - $138,537	12,675 Added 100.0%	25,350 $165,000
Q4 2020 Feb 12, 2021	BUY	$4.58 - $7.14 $58,051 - $90,499	12,675 New	12,675 $79,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.